These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 20846376)

  • 1. LPS- induced inflammation exacerbates phospho-tau pathology in rTg4510 mice.
    Lee DC; Rizer J; Selenica ML; Reid P; Kraft C; Johnson A; Blair L; Gordon MN; Dickey CA; Morgan D
    J Neuroinflammation; 2010 Sep; 7():56. PubMed ID: 20846376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer's disease.
    Kitazawa M; Oddo S; Yamasaki TR; Green KN; LaFerla FM
    J Neurosci; 2005 Sep; 25(39):8843-53. PubMed ID: 16192374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased tauopathy drives microglia-mediated clearance of beta-amyloid.
    Chen W; Abud EA; Yeung ST; Lakatos A; Nassi T; Wang J; Blum D; Buée L; Poon WW; Blurton-Jones M
    Acta Neuropathol Commun; 2016 Jun; 4(1):63. PubMed ID: 27339073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tau reduction in the presence of amyloid-β prevents tau pathology and neuronal death in vivo.
    DeVos SL; Corjuc BT; Commins C; Dujardin S; Bannon RN; Corjuc D; Moore BD; Bennett RE; Jorfi M; Gonzales JA; Dooley PM; Roe AD; Pitstick R; Irimia D; Frosch MP; Carlson GA; Hyman BT
    Brain; 2018 Jul; 141(7):2194-2212. PubMed ID: 29733334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic oral application of a periodontal pathogen results in brain inflammation, neurodegeneration and amyloid beta production in wild type mice.
    Ilievski V; Zuchowska PK; Green SJ; Toth PT; Ragozzino ME; Le K; Aljewari HW; O'Brien-Simpson NM; Reynolds EC; Watanabe K
    PLoS One; 2018; 13(10):e0204941. PubMed ID: 30281647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-10 deficiency exacerbates inflammation-induced tau pathology.
    Weston LL; Jiang S; Chisholm D; Jantzie LL; Bhaskar K
    J Neuroinflammation; 2021 Jul; 18(1):161. PubMed ID: 34275478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurofibrillary tangle formation by introducing wild-type human tau into APP transgenic mice.
    Umeda T; Maekawa S; Kimura T; Takashima A; Tomiyama T; Mori H
    Acta Neuropathol; 2014 May; 127(5):685-98. PubMed ID: 24531886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurofibrillary and neurodegenerative pathology in APP-transgenic mice injected with AAV2-mutant TAU: neuroprotective effects of Cerebrolysin.
    Ubhi K; Rockenstein E; Doppler E; Mante M; Adame A; Patrick C; Trejo M; Crews L; Paulino A; Moessler H; Masliah E
    Acta Neuropathol; 2009 Jun; 117(6):699-712. PubMed ID: 19252918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prodromal neuroinflammatory, cholinergic and metabolite dysfunction detected by PET and MRS in the TgF344-AD transgenic rat model of AD: a collaborative multi-modal study.
    Chaney AM; Lopez-Picon FR; Serrière S; Wang R; Bochicchio D; Webb SD; Vandesquille M; Harte MK; Georgiadou C; Lawrence C; Busson J; Vercouillie J; Tauber C; Buron F; Routier S; Reekie T; Snellman A; Kassiou M; Rokka J; Davies KE; Rinne JO; Salih DA; Edwards FA; Orton LD; Williams SR; Chalon S; Boutin H
    Theranostics; 2021; 11(14):6644-6667. PubMed ID: 34093845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy.
    Selenica ML; Brownlow M; Jimenez JP; Lee DC; Pena G; Dickey CA; Gordon MN; Morgan D
    Neurodegener Dis; 2013; 11(4):165-81. PubMed ID: 22796753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer's disease.
    Streit WJ; Braak H; Xue QS; Bechmann I
    Acta Neuropathol; 2009 Oct; 118(4):475-85. PubMed ID: 19513731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early depletion of CA1 neurons and late neurodegeneration in a mouse tauopathy model.
    Helboe L; Egebjerg J; Barkholt P; Volbracht C
    Brain Res; 2017 Jun; 1665():22-35. PubMed ID: 28411086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-dependent effects of microglial inhibition in vivo on Alzheimer's disease neuropathology using bioactive-conjugated iron oxide nanoparticles.
    Glat M; Skaat H; Menkes-Caspi N; Margel S; Stern EA
    J Nanobiotechnology; 2013 Sep; 11():32. PubMed ID: 24059692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic background modifies neurodegeneration and neuroinflammation driven by misfolded human tau protein in rat model of tauopathy: implication for immunomodulatory approach to Alzheimer's disease.
    Stozicka Z; Zilka N; Novak P; Kovacech B; Bugos O; Novak M
    J Neuroinflammation; 2010 Oct; 7():64. PubMed ID: 20937161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microglial activation is required for Abeta clearance after intracranial injection of lipopolysaccharide in APP transgenic mice.
    Herber DL; Mercer M; Roth LM; Symmonds K; Maloney J; Wilson N; Freeman MJ; Morgan D; Gordon MN
    J Neuroimmune Pharmacol; 2007 Jun; 2(2):222-31. PubMed ID: 18040847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of microglia in processing and spreading of bioactive tau seeds in Alzheimer's disease.
    Hopp SC; Lin Y; Oakley D; Roe AD; DeVos SL; Hanlon D; Hyman BT
    J Neuroinflammation; 2018 Sep; 15(1):269. PubMed ID: 30227881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of CX3CR1 and Fractalkine Chemokines in Amyloid Beta Clearance and p-Tau Accumulation in Alzheimer's Disease (AD) Rodent Models: Is Fractalkine a Systemic Biomarker for AD?
    Merino JJ; Muñetón-Gómez V; Alvárez MI; Toledano-Díaz A
    Curr Alzheimer Res; 2016; 13(4):403-12. PubMed ID: 26567742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of tau-pathology on charged multivesicular body protein 2b (CHMP2B).
    Midani-Kurçak JS; Dinekov M; Puladi B; Arzberger T; Köhler C
    Brain Res; 2019 Mar; 1706():224-236. PubMed ID: 30414727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of spleen tyrosine kinase and tau phosphorylated at tyrosine 18 in a mouse model of tauopathy and in the human hippocampus.
    Köhler C; Fuhr V; Dinekov M
    Brain Res; 2017 Dec; 1677():1-13. PubMed ID: 28919467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced Tau Aggregation in the Presence of Amyloid β.
    Bennett RE; DeVos SL; Dujardin S; Corjuc B; Gor R; Gonzalez J; Roe AD; Frosch MP; Pitstick R; Carlson GA; Hyman BT
    Am J Pathol; 2017 Jul; 187(7):1601-1612. PubMed ID: 28500862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.